NOTCH2 and neoplasm: Indeed, the study by Nagumo Y et al. [89], by integrating gene alterations and tumour infiltrating lymphocyte profiling, could associate NOTCH2 mutations to clinical complete response to therapy (atezolizumab and radiation therapy) in MIBC.